LABORATORY RESEARCH HIF-1 Regulates CD47 Expression in Breast Cancer Cells to Promote Evasion of Phagocytosis and Maintenance of Cancer Stem Cells Researchers report that hypoxia-inducible factor 1 (HIF-1) directly activates transcription of the CD47 gene in hypoxic breast cancer cells. [Proc Natl Acad Sci USA] Abstract Aberrantly Upregulated TRAP1 Is Required for Tumorigenesis of Breast Cancer Investigators showed that tumor necrosis factor receptor-associated protein 1 (TRAP1) is aberrantly upregulated in breast tumors compared to control tissues. [Oncotarget] Full Article Trastuzumab Resistance Induces EMT to Transform HER2+ PTEN− to a Triple Negative Breast Cancer that Requires Unique Treatment Options Researchers demonstrated that continued use of trastuzumab in HER2+ cells with loss of PTEN induces the epithelial-mesenchymal transition (EMT) and transform HER2+ to a triple negative breast cancer. [Sci Rep] Full Article Bub1 Is Required for Maintaining Cancer Stem Cells in Breast Cancer Cell Lines Scientists identified that depleting Bub1 (Budding uninhibited by benzimidazoles 1) using shRNAs reduces cancer stem cell potential of the MDA-MB-231 breast cancer cell line, resulting in inhibited formation of xenografts in immunocompromised mice. [Sci Rep] Full Article Tumor Cell-Derived Periostin Regulates Cytokines that Maintain Breast Cancer Stem Cells Researchers demonstrated that an intact periostin-integrin beta3 signaling axis is required for the maintenance of breast cancer stem cells. [Mol Cancer Res] Abstract The Breast Cancer Susceptibility Gene Product (γ-Synuclein) Alters Cell Behavior through Its Interaction with Phospholipase Cβ Using cells that mimic stage 4 breast cancer, the authors showed that down-regulation of γ-synuclein reduces the protein level of PLCβ but increases the transcript level over 40 fold. [Cell Signal] Abstract miR-33a Suppresses Breast Cancer Cell Proliferation and Metastasis by Targeting ADAM9 and ROS1 Researchers found that downregulated miR-33a in breast cancer tissues correlates with lymph node metastasis. miR-33a expression was significantly lower in the highly metastatic breast cancer cell lines than the noncancerous breast epithelial cells and non-metastatic breast cancer cells. [Protein Cell] Full Article Methyl Sulfone Blocked Multiple Hypoxia- and Non-Hypoxia-Induced Metastatic Targets in Breast Cancer Cells and Melanoma Cells Investigators showed that the molecule, methyl sulfone, normalized metastatic metabolism of hypoxic breast cancer and melanoma cells by altering several metabolic functions of the cells. [PLoS One] Full Article CLINICAL RESEARCH Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel plus Trastuzumab with or without Lapatinib CALGB 40601 examined the impact of dual HER2 blockade consisting of trastuzumab and lapatinib added to paclitaxel, considering tumor and microenvironment molecular features. [J Clin Oncol] Full Article |